Mentice Year-end Report Q4, Oct - Dec 2022
READ MORE
REGISTER
REGISTER FOR THE MENTICE YEAR-END REPORT Q4 OCT - DEC 2022 EARNINGS CALL
READ MORE
REGISTER

Mentice receives order of total SEK 5.5 million from BD (former Bard Peripheral Vascular)

Wednesday, September 9, 2020

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, receives order from BD (former Bard Peripheral Vascular) for the segment Medical Device Industry relating to solutions for physician training in the peripheral vascular area. The order covers system sales for a total order value of SEK 5.5 million and will be delivered during the third quarter 2020.

Mentice receives order from BD (APAC) relating to systems providing training solutions to support multiple BD franchises in Asia Pacific to roll out relevant procedural and product education programs in the region areas. 

The order will be accounted for in the order book for the segment Medical Device Industry during the third quarter 2020. The total value for the order amounts to SEK 5.5 million to be delivered during the third quarter 2020.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: 
goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 14.30 on September 9, 2020.  

Marketplace| Nasdaq First North Premier, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

Mentice Bokslutskommuniké, Jan - Dec 2022
LÄS MER
REGISTRERA DIG FÖR MENTICE BOKSLUTSKOMMUNIKE OKT - DEC 2022 WEBCAST
LÄS MER

Mentice receives order of total SEK 5.5 million from BD (former Bard Peripheral Vascular)

Wednesday, September 9, 2020

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, receives order from BD (former Bard Peripheral Vascular) for the segment Medical Device Industry relating to solutions for physician training in the peripheral vascular area. The order covers system sales for a total order value of SEK 5.5 million and will be delivered during the third quarter 2020.

Mentice receives order from BD (APAC) relating to systems providing training solutions to support multiple BD franchises in Asia Pacific to roll out relevant procedural and product education programs in the region areas. 

The order will be accounted for in the order book for the segment Medical Device Industry during the third quarter 2020. The total value for the order amounts to SEK 5.5 million to be delivered during the third quarter 2020.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: 
goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 14.30 on September 9, 2020.  

Marketplace| Nasdaq First North Premier, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399